CryoCath buys Endocare's cardiac ablation technology
This article was originally published in Clinica
Executive Summary
CryoCath hopes to improve its gross margins as a result of the acquisition of Endocare's SurgiFrost surgical probe system for ablating cardiac arrhythmias. It has marketed the product - which uses a malleable, single-use cryosurgical probe - since its launch in June 2002, and says that manufacturing the product in-house will reduce expenses.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.